Publication date: Available online 9 January 2016
Source:Medical Hypotheses
Author(s): Valentino Rački, Daniela Petrić, Natalia Kučić, Nika Gržeta, Kristina Jurdana, Ika Rončević-Gržeta
Cortical gray matter loss in schizophrenia remains a great therapeutic difficulty. Each psychotic episode causes irreversible cortical gray matter loss, that causes the patients to never regain their previous state of functioning. Microglial cells are part of the innate immune system and their functions, among others, include phagocytosis and release of neurotrophic factors. They have a key impact on developmental and plasticity-induced removal of neuronal precursors, live-but-stressed neurons and synapses, while also stimulating synaptic growth and development. We hypothesize that microglia are the culprit for the cortical gray matter loss in schizophrenia through abnormal synaptic pruning, phagocytosis of stressed neurons and lacking neurotrophic factor release. Furthermore, we propose a research that could validate the hypotheses using serum samples of first-episode early-onset patients. By measuring the serum levels of milk fat globule-EGF factor 8 (MFG-E8), subcomponent in the classical pathway of complement activation (C1q), brain-derived neurotrophic factor (BDNF), interleukin-6 (IL-6) and interleukin-10 (IL-10), we could gain an insight into the state of microglial activation during various stages of the disease. If this hypothesis is valid, new targeted drugs could be developed in order to reduce the deterioration of cortical gray matter, thereby possibly improving negative symptoms and cognitive deficits.
from #Medicine via ola Kala on Inoreader http://ift.tt/1TNJWf0
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
Ιανουαρίου
(578)
-
▼
Ιαν 10
(24)
- Protective effect of Rhei Rhizoma on reflux esopha...
- Generating Primary Fibroblast Cultures from Mouse ...
- Folate Deficiency Affects Histone Methylation
- Cortical gray matter loss in schizophrenia: Could ...
- Adhesive capsulitis: An age related symptom of met...
- The Baby Food Hypothesis: An explanation why high ...
- Muscle growth across a variety of exercise modalit...
- In situ ionic liquid dispersive liquid–liquid micr...
- FTIR spectroscopy characterization of fatty-acyl-c...
- Precision mixology challenge
- Rapid assessment of singlet oxygen-induced plasma ...
- Sensitive detection of cyanide using bovine serum ...
- Multi-mycotoxin stable isotope dilution LC-MS/MS m...
- E-Health—a topic for analytical chemists?
- Development of gold nanoparticles-based aptasensor...
- Nicholas Long and Wing-Tak Wong: The chemistry of ...
- Quantitative profiling of oxylipins in plasma and ...
- One-pot green hydrothermal synthesis of fluorescen...
- Solution to rubbery egg challenge
- Development of a label-free gold nanoparticle-base...
- Experienced versus Inexperienced Interexaminer Rel...
- Intraoral Digital Impressions for Virtual Occlusal...
- Modification of the Sweetness and Stability of Swe...
- Extraction of Oleic Acid from Moroccan Olive Mill ...
-
▼
Ιαν 10
(24)
Αναζήτηση αυτού του ιστολογίου
Κυριακή 10 Ιανουαρίου 2016
Cortical gray matter loss in schizophrenia: Could microglia be the culprit?
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.